Sep 17, 2026 9:17 am EDT VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France
Sep 14, 2026 8:17 am EDT VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027
Sep 10, 2026 8:17 am EDT Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference
Aug 26, 2026 9:17 am EDT VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
Aug 26, 2026 8:17 am EDT Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis
Aug 13, 2026 4:10 pm EDT VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update
Aug 12, 2026 8:17 am EDT Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients
Aug 11, 2026 4:10 pm EDT VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update
Aug 5, 2026 8:17 am EDT Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology
